Zdrowie i gospodarka · 05/02/2019
FDA Announces Public Workshop on Generic Drug Regulatory Science Initiatives for FY 2019
The FDA is hosting a public workshop to gather input from various stakeholders on its regulatory science initiatives for generic drugs, as part of its commitment to develop an annual list of initiatives under the Generic Drug User Fee Amendments of 2017.
Source: Federal Register — Food and Drug AdministrationOpen original release →